News
Vaishali Pharma standalone net profit rises 75.42% in the September 2026 quarter
16-Nov-2026 | 10:18
Sales decline 9.81% to Rs 30.17 crore
Net profit of Vaishali Pharma rose 75.42% to Rs 2.07 crore in the quarter ended September 2026 as against Rs 1.18 crore during the previous quarter ended September 2025. Sales declined 9.81% to Rs 30.17 crore in the quarter ended September 2026 as against Rs 33.45 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 30.17 | 33.45 | -10 |
| OPM % | 6.86 | 4.13 | - |
| PBDT | 2.63 | 1.82 | 45 |
| PBT | 2.49 | 1.65 | 51 |
| NP | 2.07 | 1.18 | 75 |
Powered by Capital Market - Live News